RxDoctor Payments Data

Sarah Oddo, PA

Physician Assistant · Fulton, NYNPI 1063715068

Payments from drug & device makers

$527in general payments, 2019–2025

Across 27 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$68
  • Novo Nordisk$55
  • Astellas Pharma US Inc$54
  • AbbVie$42
  • Lilly USA, LLC$37
  • Mylan Specialty L.p.$36
  • plus $236 from 10 others

What the payments were for

  • Food & beverage$527100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$527 in reported general payments places this provider in the 65th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$40,483
Medicare patients
183
Services billed
534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide33$42,204
EliquisApixaban44$35,352
XareltoRivaroxaban20$27,625
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$16,983
MyrbetriqMirabegron19$12,309
JardianceEmpagliflozin16$10,622
Breo ElliptaFluticasone/Vilanterol14$9,451
Incruse ElliptaUmeclidinium Bromide15$5,004
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$4,621
Albuterol Sulfate HfaAlbuterol Sulfate114$4,118
Memantine Hcl25$1,804
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$1,560
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen80$1,506
PaxlovidNirmatrelvir/Ritonavir13$1,397
Donepezil Hcl20$1,384

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$55$42,20433 claims
PfizerEliquis, Paxlovid$19$36,74957 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$35$31,43846 claims
Astellas Pharma US IncMyrbetriq$54$12,30919 claims
AbbVieSynthroid$42$1,13120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Fulton

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →